ROXIAN ODOM: Open Payments
NPI 1922652049 · FLORENCE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 26 payments from 10 companies in 2025. Trend: 2023 $506 · 2024 $686 · 2025 $522
Food & beverage: $522
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 4 | $79 |
| Corium, LLC | 4 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Vanda Pharmaceuticals Inc. | 2 | $61 |
| Collegium Pharmaceutical, Inc. | 3 | $55 |
| ABBVIE INC. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
Products named: Dyanavel XR, Azstarys, CAPLYTA, Auvelity, FANAPT, Jornay PM, VRAYLAR, TRINTELLIX.
Industry payments across MS — which companies pay providers there.
